Dirk W. Kirsten
Director of Finance/CFO chez MEDARTIS HOLDING AG
Fortune : 146 601 $ au 31/03/2024
Profil
Dirk W.
Kirsten is currently the Chief Financial Officer at Medartis Holding AG since 2021.
Previously, he worked as the Head-Group Funding & Capital Markets at Roche Holding AG from 2002 to 2004, as the Group Treasurer at Syngenta AG from 2004 to 2008, and as the Chief Financial Officer at Nobel Biocare Holding AG from 2008 to 2013.
He holds a doctorate degree from Universität zu Köln.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEDARTIS HOLDING AG
0,01% | 31/12/2022 | 1 477 ( 0,01% ) | 146 601 $ | 31/03/2024 |
Postes actifs de Dirk W. Kirsten
| Sociétés | Poste | Début |
|---|---|---|
| MEDARTIS HOLDING AG | Director of Finance/CFO | 01/03/2021 |
Anciens postes connus de Dirk W. Kirsten
| Sociétés | Poste | Fin |
|---|---|---|
| NOBEL BIOCARE HOLDING AG | Director of Finance/CFO | 01/01/2013 |
| SYNGENTA | Treasurer | 01/01/2008 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2004 |
Formation de Dirk W. Kirsten
| Universität zu Köln | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| MEDARTIS HOLDING AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Syngenta AG
 Syngenta AG Chemicals: AgriculturalProcess Industries Syngenta AG specializes in crop protection and seeds production. Its products include selective and non-selective herbicides, fungicides, insecticides, as well as field crop and vegetable seeds. The company was founded on November 12, 1999 and is headquartered in Basel, Switzerland. | Process Industries |
Nobel Biocare Holding AG
 Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Nobel Biocare Holding AG is a provider in the field of innovative implant-based dental restorations - from single-tooth to fully edentulous indications. It offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems as well as diagnostics, treatment planning, guided surgery solutions and biomaterials. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems, a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning and guided surgery solutions and biomaterials. Nobel Biocare Holding was founded in 1981 and is headquartered in Kloten, Switzerland. | Health Technology |
